CLARUS THERAPEUTICS HLDGS INC | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
2023/02/15 01:29
Clarus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FYI Ltd.(.54%),Olifant Fund, Ltd.(.50%)等
2022/07/07 04:00
Clarus Therapeutics | 4:持股变动声明
2022/06/10 08:06
Clarus Therapeutics | 4:持股变动声明
2022/06/10 08:04
Clarus Therapeutics | 4:持股变动声明
2022/06/10 08:02
Clarus Therapeutics | 4:持股变动声明
2022/06/10 08:02
Clarus Therapeutics | 4:持股变动声明
2022/06/10 08:00
Clarus Therapeutics | 4:持股变动声明
2022/04/28 04:09
Clarus Therapeutics | 4/A:持股变动声明(修正)-股东 THOMAS MCNERNEY & PARTNERS LP
2022/04/26 05:17
Clarus Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-James E. Thomas(0.2%),Thomas, McNerney & Partners, LLC(0.1%)等
2022/04/22 08:43
Clarus Therapeutics | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
2022/02/15 07:22
Clarus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-CVI Investments, Inc.(1.1%),Heights Capital Management, Inc.(1.1%)
2022/02/15 04:24
Clarus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Lighthouse Investment Partners, LLC(0%),MAP 136 Segregated Portfolio, a segregated portfolio of LMA SPC(0%)等
2022/02/15 00:35
Clarus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Bracebridge Capital, LLC(8.3%),FFI Fund Ltd.(6.1%)等
2022/02/15 00:34
Clarus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Beryl Capital Management LLC(0%),Beryl Capital Management LP(0%)等
2022/02/12 07:51
Clarus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Hudson Bay Capital Management LP(0%),Sander Gerber(0%)
2022/02/09 05:28
Clarus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-ANDREW M. WEISS, PH.D.(0.00%)
2022/02/05 00:49
Clarus Therapeutics | D:发行公告
2021/12/21 21:59
Clarus Therapeutics | 4:持股变动声明
2021/12/15 08:03
Clarus Therapeutics | 4:持股变动声明
2021/12/15 08:02
暂无数据
暂无数据